The company is asking the court to continue business practices and a potential sale of assets during the bankruptcy process, according to SEC filings. Shares of InVivo fell 48% amid news of the filing, according to Market Watch.
InVivo Therapeutics’ implants aim to help patients with acute thoracic spinal cord injuries, according to its website.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.